Gaudium IVF sees Q1 revenue up 9.1% to ₹19.4 Cr. EBITDA impacted by expansion costs. Board approves Lucknow hospital and new Delhi IVF hub begins operations.
Gaudium IVF launches AI-powered Signature Labs, marking the start of its 19-centre expansion. This move aims to enhance fertility care accessibility and quality through advanced technology and standardized laboratory protocols.
Gaudium IVF reports strong Q4FY26 results with revenue up 13% YoY and PAT up 30% YoY. FY26 revenue grew 48%. Company integrates AI-led embryology, plans 19 new hubs.
Gaudium IVF's petition by an operational creditor has been rejected by the NCLT, with no expected impact on financial or operational activities.
Gaudium IVF introduces AI-led infertility treatment, integrating advanced embryology systems for improved success rates and patient outcomes. This partnership brings globally advanced technology to India.
